News
-
-
-
COMMUNIQUÉ DE PRESSE
Leads To Development Joins Clarenta Group, Strengthening Early-Stage Drug Development Expertise
Clarenta Group strengthens early-stage drug development expertise by adding Leads To Development (L2D) through a majority investment, enhancing support for biotech and pharmaceutical sponsors